Literature DB >> 10692249

Activin A exerts both pro- and anti-inflammatory effects on human term gestational tissues.

J A Keelan1, R L Zhou, M D Mitchell.   

Abstract

There is a growing appreciation of the importance of activin as a modulator of immune function. The aim of the present study was to determine whether activin A exerts any effects on cytokine and prostaglandin (PG) production by the tissues of pregnancy. Explant cultures were established for amnion, choriodecidual and placental tissues derived from pregnancies delivered at term by Caesarean section (n=5 placentae). Explants were treated with activin A (0.5, 5 and 50 ng/ml) in serum-free Ham's F12/DME media for 24 h (n=3-4 replicates). Production rates of interleukin (IL)-1beta, IL-6, IL-8, tumour necrosis factor-alpha (TNF-alpha) and PGE(2)were determined using immunoassay. Differences between treatment groups were analysed by ANOVA followed by Dunnett's test;P< 0.05 was considered to be significant. Amnion IL-6 production exhibited biphasic responses to activin A: at 5 ng/ml activin A, IL-6 production was significantly stimulated (to 246+/-74.6 per cent of control (mean+/-sem), while at 50 ng/ml it was significantly inhibited (to 46+/-7.4 per cent of control). IL-8 and PGE(2)production by amnion showed significant responses to activin A that were similar to those of IL-6. No significant effects of activin A were observed on choriodecidual and placental IL-6, IL-8 and PGE(2)production. However, TNF-alpha production was significantly inhibited by 50 ng/ml activin A in both choriodecidual and placental explants (to 43+/-9.7 per cent and 51+/-6.7 per cent of control, respectively). Placental IL-1beta production was not altered by treatment with activin A at any concentration. These findings support the concept of activin as an immune modulator in tissues of pregnancy. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692249     DOI: 10.1053/plac.1999.0451

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  13 in total

1.  Immunohistochemical labeling of the inhibin/activin betaC subunit in normal human placental tissue and chorionic carcinoma cell lines.

Authors:  Tobias Weissenbacher; Ansgar Brüning; Tanja Kimmich; Josef Makovitzky; Andrea Gingelmaier; Ioannis Mylonas
Journal:  J Histochem Cytochem       Date:  2010-05-10       Impact factor: 2.479

2.  Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia.

Authors:  Kristian L Jones; Ashley Mansell; Shane Patella; Bernadette J Scott; Mark P Hedger; David M de Kretser; David J Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

3.  Placental and maternal serum activin A in spontaneous and induced labor in late-term pregnancy.

Authors:  L Funghi; M Torricelli; R Novembri; S Vannuccini; G Cevenini; M Di Tommaso; F M Severi; F Petraglia
Journal:  J Endocrinol Invest       Date:  2017-06-13       Impact factor: 4.256

4.  Beneficial effects of follistatin in hepatic ischemia-reperfusion injuries in rats.

Authors:  Mami Kanamoto; Mitsuo Shimada; Yuji Morine; Tomoharu Yoshizumi; Satoru Imura; Toru Ikegami; Hiroki Mori; Yusuke Arakawa
Journal:  Dig Dis Sci       Date:  2010-09-08       Impact factor: 3.199

5.  Modulation of amniotic fluid activin-a and inhibin-a in women with preterm premature rupture of the membranes and infection-induced preterm birth.

Authors:  Victor A Rosenberg; Irina A Buhimschi; Antonette T Dulay; Sonya S Abdel-Razeq; Emily A Oliver; Christina M Duzyj; Heather Lipkind; Christian M Pettker; Catalin S Buhimschi
Journal:  Am J Reprod Immunol       Date:  2011-10-13       Impact factor: 3.886

6.  Activin A is stimulated by tumor necrosis factor-alpha and modulates collagen gene expression in human amniotic cells.

Authors:  Y Abe; M Komatsubara; M Saito; M Toda; H Shinozaki; T Tamura; Y Kasahara; H Sedakata; T Minegishi
Journal:  J Endocrinol Invest       Date:  2013-02-04       Impact factor: 4.256

7.  Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle.

Authors:  Ioannis Mylonas; Udo Jeschke; Irmgard Wiest; Anna Hoeing; Julia Vogl; Naim Shabani; Christina Kuhn; Sandra Schulze; Markus S Kupka; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2004-10-12       Impact factor: 4.304

8.  TGFβ and activin A in the tumor microenvironment in colorectal cancer.

Authors:  Jasmin Zessner-Spitzenberg; Alexandra L Thomas; Nancy L Krett; Barbara Jung
Journal:  Gene Rep       Date:  2019-09-12

9.  Validation of murine and human placental explant cultures for use in sex steroid and phase II conjugation toxicology studies.

Authors:  Brittany L Sato; Monika A Ward; Joshua M Astern; Claire E Kendal-Wright; Abby C Collier
Journal:  Toxicol In Vitro       Date:  2014-10-02       Impact factor: 3.500

Review 10.  Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection.

Authors:  Noboru Uchide; Kunio Ohyama; Toshio Bessho; Makoto Takeichi; Hiroo Toyoda
Journal:  Mediators Inflamm       Date:  2012-07-31       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.